Chronic Disease Management Market Outlook:
Chronic Disease Management Market size was over USD 6.54 billion in 2025 and is poised to exceed USD 18.91 billion by 2035, witnessing over 11.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of chronic disease management is estimated at USD 7.2 billion.
The growth in the chronic disease management market is impelled by the increase in the prevalence of various types of related ailments, which is inflating the need for long-term intensive care. There is a worldwide upsurge in chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD), chronic kidney disorder (CKD), and cancer, fostering a large consumer base for this sector. In 2021, the number of diabetic people aged between 20 and 79 was 536.6 million in the world, which is projected to reach 783.2 million by 2045 (NLM). Simultaneously, the expected annual new and death cases of cancer around the globe are 26.0 million and 17.0 million by 2030: NLM. On the other hand, globally, the age-standardized rate of mortality for CKD is poised to be 21.26 per 100,000 by 2032: Frontiers.
This demography also comes with a huge economic burden, demanding more accessible and long-acting solutions, which can be achieved by using the commodities from the chronic disease management market. According to the NLM estimations, the net global expense on these health conditions is to be USD 47.0 trillion by 2030. This is pushing medical service providers and MedTech pioneers to cultivate solutions with affordable payers’ pricing. On this note, NLM published a study in June 2020 demonstrating the benefits of implementing an integrated chronic disease management (ICDM) model in primary healthcare clinics in South Africa. The results revealed the implementation cost per clinic and cost per patient per visit to be USD 1,48,446.0 and USD 6.0, respectively.
